Loading clinical trials...
Loading clinical trials...
The primary objective is to assess whether 16 weeks of treatment with dupilumab as an adjunct to Timothy Grass Subcutaneous Immunotherapy (SCIT) improves upon the efficacy of Timothy Grass SCIT to red...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Regeneron Pharmaceuticals
Collaborators
NCT06547372 · Atopic Dermatitis, Atopic, and more
NCT07419230 · Allergic Rhinitis
NCT06732414 · Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
NCT05494346 · Acute Rhinitis, Nasal Obstruction, and more
NCT07110311 · Allergic Rhinitis
Regeneron Investigational Site
Los Angeles, California
Regeneron Investigational Site
Mountain View, California
Regeneron Investigational Site
Walnut Creek, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions